Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

Autor: Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E, Gelenberg, A J, Lydiard, R B, Rudolph, R L, Aguiar, L, Haskins, J T, Salinas, E

Publikováno v: JAMA: Journal of the American Medical Association; 6/21/2000, Vol. 283 Issue 23, p3082-3088, 7p

Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.

Autor: Entsuah, A. R., Rudolph, R. L., Hackett, D., Miska, S.

Publikováno v: International Clinical Psychopharmacology; 1996 Supplement 3, Vol. 11, p137-145, 9p

Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.

Autor: Rudolph, R. L.¹

Publikováno v: Acta Psychiatrica Scandinavica. Supplementum. Dec2002 Supplement 415, Vol. 106, p24-30. 0p. 1 Chart, 5 Graphs.

Evidence of the dual mechanisms of action of venlafaxine.

Autor: Harvey AT; Psychiatric Research Institute and the Department of Psychiatry, University of Kansas School of Medicine, Wichita 67214-2878, USA. aharvey@kumc.edu, Rudolph RL, Preskorn SH

Publikováno v: Archives of general psychiatry [Arch Gen Psychiatry] 2000 May; Vol. 57 (5), pp. 503-9.

Goal of antidepressant therapy: response or remission and recovery?

Autor: Rudolph RL; Department of Clinical Research and Development, Wyeth-Ayerst Research, Radnor, PA.

Publikováno v: The Journal of clinical psychiatry [J Clin Psychiatry] 1999; Vol. 60 Suppl 6, pp. 3-4.